These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28849122)
1. Downregulation of TM7SF4 inhibits cell proliferation and metastasis of A549 cells through regulating the PI3K/AKT/mTOR signaling pathway. Yang X; Song X; Wang X; Liu X; Peng Z Mol Med Rep; 2017 Nov; 16(5):6122-6127. PubMed ID: 28849122 [TBL] [Abstract][Full Text] [Related]
2. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway. Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑21 increases cell viability and suppresses cellular apoptosis in non‑small cell lung cancer by regulating the PI3K/Akt signaling pathway. Wang T; Cai Z; Hong G; Zheng G; Huang Y; Zhang S; Dai J Mol Med Rep; 2017 Nov; 16(5):6506-6511. PubMed ID: 28901419 [TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA FER1L4 inhibits cell proliferation and metastasis through regulation of the PI3K/AKT signaling pathway in lung cancer cells. Gao X; Wang N; Wu S; Cui H; An X; Yang Y Mol Med Rep; 2019 Jul; 20(1):182-190. PubMed ID: 31115514 [TBL] [Abstract][Full Text] [Related]
5. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
6. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR. Ma HP; Kong WX; Li XY; Li W; Zhang Y; Wu Y Oncol Rep; 2019 Mar; 41(3):1549-1559. PubMed ID: 30747217 [TBL] [Abstract][Full Text] [Related]
7. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
8. Skullcapflavone I suppresses proliferation of human lung cancer cells via down-regulating microRNA-21. Yang Y; An R; Feng T; Qin X; Zhang J; Bo Y; Niu B Exp Mol Pathol; 2019 Oct; 110():104285. PubMed ID: 31301304 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway. Zhu Q; Liang X; Dai J; Guan X Int J Clin Exp Pathol; 2015; 8(8):9175-81. PubMed ID: 26464663 [TBL] [Abstract][Full Text] [Related]
10. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung carcinoma via miR‑1183 and PI3K/PKB pathway. Wu W; Xi W; Li H; Yang M; Yao X Int J Mol Med; 2020 Jun; 45(6):1814-1824. PubMed ID: 32236577 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway. Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW Oncol Rep; 2018 Nov; 40(5):2944-2954. PubMed ID: 30226581 [TBL] [Abstract][Full Text] [Related]
13. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway. Yin Y; Sui C; Meng F; Ma P; Jiang Y Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627 [TBL] [Abstract][Full Text] [Related]
14. Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways. Jia J; Martin TA; Ye L; Meng L; Xia N; Jiang WG; Zhang X Int J Mol Med; 2018 Jan; 41(1):275-283. PubMed ID: 29115573 [TBL] [Abstract][Full Text] [Related]
15. Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma. Liu Y; Yang H; Chen T; Luo Y; Xu Z; Li Y; Yang J PLoS One; 2015; 10(5):e0127092. PubMed ID: 25978653 [TBL] [Abstract][Full Text] [Related]
16. FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways. Hu H; Wang F; Wang M; Liu Y; Wu H; Chen X; Lin Q Int J Med Sci; 2020; 17(6):807-814. PubMed ID: 32218702 [TBL] [Abstract][Full Text] [Related]
17. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer. Zhang P; Yu S; Li H; Liu C; Li J; Lin W; Gao A; Wang L; Gao W; Sun Y FEBS Lett; 2015 Aug; 589(17):2248-56. PubMed ID: 26149216 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells. Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431 [TBL] [Abstract][Full Text] [Related]
19. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway. Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738 [TBL] [Abstract][Full Text] [Related]
20. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]